Biocryst Pharmaceuticals (BCRX) Tax Rate Growth (1y) (2022 - 2026)
Biocryst Pharmaceuticals (BCRX) Tax Rate Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Biocryst Pharmaceuticals | 2.37 Bn | 2.30 Bn | 151.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,592.00 |
| Dec 31, 2025 | 397.00 |
| Sep 30, 2025 | -198.00 |
| Jun 30, 2025 | 2,298.00 |
| Mar 31, 2025 | 9,682.00 |
| Dec 31, 2024 | -536.00 |
| Sep 30, 2024 | -344.00 |
| Jun 30, 2024 | -38.00 |
| Mar 31, 2024 | 23.00 |
| Dec 31, 2023 | 237.00 |
| Sep 30, 2023 | 279.00 |
| Jun 30, 2023 | 48.00 |
| Mar 31, 2023 | -90.00 |
| Dec 31, 2022 | 1,440.00 |